4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass
2015 · Blood · 11 citations
https://doi.org/10.1182/blood.v126.23.264.264
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
182
Citations
7
h-index
6
i10-index
Fang Bao is an academic researcher from Nantong University. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Immune Cell Function and Interaction & Lung Cancer Research Studies. The author has an h-index of 7, co-authored 23 publications.
ORCID: 0000-0002-2979-5973https://doi.org/10.1182/blood.v126.23.264.264
https://doi.org/10.1186/s12872-021-02238-5
Click to start Chat